The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300mg powder for injection vial with diluent vial (143657)

ARTG ID 143657

ARTG Name

ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300mg powder for injection vial with diluent vial

Product name

ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300mg powder for injection vial with diluent vial

ARTG Date

24 March 2009

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

olanzapine pamoate monohydrate

Licence category

RE

Licence status

A

Summary

Product Information

Consumer Medicine Information

ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300 mg powder for injection vial with diluent vial, Eli Lilly Australia Pty Ltd, CON-1084

16 March 2023

Section 14 consent

Consent to while noncompliant with standards.
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300 mg powder for injection vial with diluent vial, Eli Lilly Australia Pty Ltd, CON-1219

22 March 2024

Section 14 consent

Consent to while noncompliant with standards.
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300mg powder for injection vial with diluent vial, Pharmaco Australia Ltd, CON-1334

7 March 2025

Section 14 consent

Consent to while noncompliant with standards.